- Home
- ELPC vs PCVX Comparison
ELPC vs PCVX Comparison
Compare ELPC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELPC | PCVX |
|---|---|---|
| Founded | 1954 | 2013 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELPC | PCVX |
|---|---|---|
| Price | $9.00 | $48.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $101.67 |
| AVG Volume (30 Days) | 12.1K | ★ 1.5M |
| Earning Date | 02-27-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $4,681,123,759.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.83 | N/A |
| P/E Ratio | $16.76 | ★ N/A |
| Revenue Growth | ★ 12.38 | N/A |
| 52 Week Low | $5.04 | $27.66 |
| 52 Week High | $10.51 | $93.77 |
Technical Indicators
Market Signals| Indicator | ELPC | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 59.27 |
| Support Level | $9.09 | $42.40 |
| Resistance Level | $9.87 | $45.15 |
| Average True Range (ATR) | 0.19 | 1.94 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 4.26 | 91.30 |
Price Performance
Historical ComparisonAbout ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.